secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0001493152-22-031981
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim Q3 revenue up 42% YoY to $20.5M; net loss narrows to $1.6M
----------------------------------------------------------------

- Revenue $20.5M (+42% YoY); net loss $1.6M vs $10.9M loss in Q3 2021.
- Gross margin improved to 16.2% from 12.4% a year ago.
- Shipped $13.9M in new tablet orders, leveraging ODM capabilities.
- Closed $17.5M strategic equity transaction at $0.84 per share.
- Next-gen XP10 5G rugged smartphone shipping to major carriers in Q4 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315222031981/0001493152-22-031981-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315222031981/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-031981

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer